Summit Therapeutics Inc. - stock earnings
SMMT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -14.7 million USD | ? USD |
| 2022Q4 | -19.2 million USD | ? USD |
| 2022Q3 | -21.4 million USD | 220000 USD |
| 2022Q2 | -16.8 million USD | 235000 USD |
| 2022Q1 | -21.4 million USD | 250000 USD |
| 2021Q4 | -27.1 million USD | 251000 USD |
| 2021Q3 | -19.6 million USD | 1.3 million USD |
| 2021Q2 | -24.4 million USD | 57000 USD |
| 2021Q1 | -17.5 million USD | 192000 USD |
| 2020Q4 | -13.4 million USD | 185000 USD |
| 2020Q3 | -17.7 million USD | 181000 USD |
| 2020Q2 | -15.2 million USD | 170000 USD |
| 2019Q1 | -5.3 million USD | 375000 USD |
SMMT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -614.9 million USD | ? USD |
| 2023 | -74.4 million USD | 704295 USD |
| 2022 | -86.1 million USD | 1.8 million USD |
| 2021 | -52.7 million USD | 860000 USD |
| 2020 | 5.0 million USD | 43.0 million USD |
| 2019 | 9.9 million USD | 56.4 million USD |
| 2018 | -10.1 million USD | 36.0 million USD |
| 2017 | -26.7 million USD | 2.9 million USD |
| 2016 | -24.3 million USD | 2.9 million USD |
| 2015 | -17.1 million USD | 2.3 million USD |
| 2014 | -10.1 million USD | 2.3 million USD |
| 2013 | -6.7 million USD | 2.9 million USD |
| 2012 | -4.2 million USD | 2.8 million USD |
| 2011 | -7.4 million USD | 1.2 million USD |
| 2010 | -8.7 million USD | 301945 USD |
| 2009 | -32.3 million USD | 266639 USD |
| 2008 | -20.1 million USD | 6.0 million USD |
| 2007 | -5.9 million USD | 2.0 million USD |
| 2006 | -1.9 million USD | 947892 USD |
| 2005 | -86611 USD | 212761 USD |
| 2004 | -41963 USD | 1824 USD |
SMMT
Price: $4.39
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -3.76
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 252593
Ebitda: -3.9 millionMarket Capitalization: 2.8 billion